share_log

Invivyd | CORRESP: CORRESP

SEC announcement ·  Apr 19 02:09
Summary by Futu AI
Invivyd, Inc., a biotechnology company, has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, initially filed on February 9, 2024. The company seeks to have the Registration Statement declared effective by 4:00 p.m. Eastern Time on April 19, 2024. This request was made under Rule 461 of the General Rules and Regulations under the Securities Act of 1933. Invivyd's Chief Legal Officer and Corporate Secretary, Jill Andersen, signed the request, and any inquiries or communications regarding this acceleration are to be directed to Stephen M. Nicolai of Hogan Lovells US LLP.
Invivyd, Inc., a biotechnology company, has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, initially filed on February 9, 2024. The company seeks to have the Registration Statement declared effective by 4:00 p.m. Eastern Time on April 19, 2024. This request was made under Rule 461 of the General Rules and Regulations under the Securities Act of 1933. Invivyd's Chief Legal Officer and Corporate Secretary, Jill Andersen, signed the request, and any inquiries or communications regarding this acceleration are to be directed to Stephen M. Nicolai of Hogan Lovells US LLP.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.